493280 — IMBiologics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for IMBiologics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	14,003	30,662	72,660
Net Total Accounts Receivable
Net Total Receivables	287	1,606	646
Prepaid Expenses
Total Current Assets	14,444	33,988	73,656
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,538	1,394	1,410
Net Intangible Assets
Other Long Term Assets
Total Assets	16,774	36,134	75,300
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	81,816	112,650	1,009
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	82,600	113,336	1,808
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	-65,826	-77,202	73,491
Total Liabilities & Shareholders' Equity	16,774	36,134	75,300
Total Common Shares Outstanding